NRGN and early-onset autosomal dominant Alzheimer disease: In an earlier retrospective cohort study comprised of 19 healthy controls with normal cognitive function and 331 individuals with various neurodegenerative diseases, the median CSF neurogranin level was greater in Alzheimer’s disease patients compared with the other disease groups and controls [267] (Table 3).